Literature DB >> 19760481

Primary sclerosing cholangitis with elevated serum IgG4 levels and/or infiltration of abundant IgG4-positive plasma cells.

Masanori Koyabu1, Kazushige Uchida, Norimasa Fukata, Takeo Kusuda, Tsukasa Ikeura, Yutaku Sakaguchi, Katsunori Yoshida, Masaaki Shimatani, Toshiro Fukui, Mitsunobu Matsushita, Yoshiko Uemura, Masaki Kaibori, Makoto Takaoka, Akiyoshi Nishio, Kazuichi Okazaki.   

Abstract

Immunoglobin G4-related sclerosing cholangitis (IgG4-SC) is recognized as one of the systemic sclerosing diseases characterized by abundant IgG4-positive plasma cells with effective steroid therapy. On the other hand, primary sclerosing cholangitis (PSC), recognized as a sclerosing cholangitis of unknown origin without steroid efficacy, has been often clinically confused with IgG4-SC. To date, the prognosis of IgG4-SC is unclear, while the prognosis of PSC is well known to be poor. Therefore, it is clinically very important to be able to distinguish IgG4-SC from PSC. However, at the present time it still remains unclear whether PSC may sometimes be misdiagnosed as IgG4-SC or not. Herein, we report three rare cases of PSC with elevated serum IgG4 levels and/or an infiltration of abundant IgG4-positive plasma cells in the liver: a young male with ulcerative colitis (UC), and elderly female and a young female, each with elevated serum IgG4 levels. The first two patients showed infiltration of abundant IgG4-positive plasma cells in the portal area of the liver without response to steroid therapy. From our experiences, we emphasize that some patients with PSC, who do not respond to steroid therapy, show elevated serum IgG4 levels and/or infiltration of abundant IgG4-positive plasma cells, although the mechanism still remains unclear.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19760481     DOI: 10.1007/s00535-009-0130-y

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  41 in total

1.  Effective steroid pulse therapy for the biliary stenosis caused by autoimmune pancreatitis.

Authors:  Mitsunobu Matsushita; Masao Yamashina; Tsukasa Ikeura; Massaki Shimatani; Kazushige Uchida; Makoto Takaoka; Kazuichi Okazaki
Journal:  Am J Gastroenterol       Date:  2007-01       Impact factor: 10.864

2.  Extrapancreatic lesions in autoimmune pancreatitis.

Authors:  Terumi Kamisawa; Naoto Egawa; Hitoshi Nakajima; Kouji Tsuruta; Atsutake Okamoto
Journal:  J Clin Gastroenterol       Date:  2005 Nov-Dec       Impact factor: 3.062

3.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

Review 4.  Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis.

Authors:  K Yoshida; F Toki; T Takeuchi; S Watanabe; K Shiratori; N Hayashi
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

5.  Primary sclerosing cholangitis in Japan--analysis of 192 cases.

Authors:  H Takikawa; T Manabe
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

6.  Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis.

Authors:  Takahiro Nakazawa; Hirotaka Ohara; Hitoshi Sano; Shigeru Aoki; Shinya Kobayashi; Tetsu Okamoto; Hideto Imai; Tomoyuki Nomura; Takashi Joh; Makoto Itoh
Journal:  Gastrointest Endosc       Date:  2004-12       Impact factor: 9.427

7.  Distinct clinicopathological entity 'autoimmune pancreatitis-associated sclerosing cholangitis'.

Authors:  Takeshi Uehara; Hideaki Hamano; Shigeyuki Kawa; Kenji Sano; Takayuki Honda; Hiroyoshi Ota
Journal:  Pathol Int       Date:  2005-07       Impact factor: 2.534

8.  Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience.

Authors:  Suresh T Chari; Thomas C Smyrk; Michael J Levy; Mark D Topazian; Naoki Takahashi; Lizhi Zhang; Jonathan E Clain; Randall K Pearson; Bret T Petersen; Santhi Swaroop Vege; Michael B Farnell
Journal:  Clin Gastroenterol Hepatol       Date:  2006-07-14       Impact factor: 11.382

9.  IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?

Authors:  Yoh Zen; Kenichi Harada; Motoko Sasaki; Yasunori Sato; Koichi Tsuneyama; Joji Haratake; Hiroshi Kurumaya; Kazuyoshi Katayanagi; Shinji Masuda; Hideki Niwa; Hideo Morimoto; Atsuo Miwa; Akio Uchiyama; Bernard C Portmann; Yasuni Nakanuma
Journal:  Am J Surg Pathol       Date:  2004-09       Impact factor: 6.394

10.  Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis.

Authors:  Yoh Zen; Takahiko Fujii; Kenichi Harada; Mitsuhiro Kawano; Kazunori Yamada; Masayuki Takahira; Yasuni Nakanuma
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

View more
  7 in total

Review 1.  IgG4-associated cholangitis: a comprehensive review.

Authors:  Lowiek M Hubers; Lucas J Maillette de Buy Wenniger; Marieke E Doorenspleet; Paul L Klarenbeek; Joanne Verheij; Erik A Rauws; Thomas M van Gulik; Ronald P J Oude Elferink; Stan F J van de Graaf; Niek de Vries; Ulrich Beuers
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 2.  Usefulness of steroid administration for diagnosis of IgG4-related sclerosing cholangitis.

Authors:  Norio Kubo; Hideki Suzuki; Tsutomu Kobayashi; Kenichiro Araki; Shigeru Sasaki; Wataru Wada; Hiroyuki Kuwano
Journal:  Int Surg       Date:  2012 Apr-Jun

3.  Pathologies Associated with Serum IgG4 Elevation.

Authors:  Mikael Ebbo; Aurélie Grados; Emmanuelle Bernit; Frederic Vély; José Boucraut; Jean-Robert Harlé; Laurent Daniel; Nicolas Schleinitz
Journal:  Int J Rheumatol       Date:  2012-08-26

Review 4.  Cholangiocarcinoma with respect to IgG4 Reaction.

Authors:  Kenichi Harada; Yasuni Nakanuma
Journal:  Int J Hepatol       Date:  2014-07-15

5.  The importance of IgG4 screening in patients diagnosed with primary sclerosing cholangitis in the past: A case rediagnosed as IgG4-SC after 10 years.

Authors:  Yanni Li; Lu Zhou; Xin Zhao; Wenjing Song; Nathasha Karunaratna; Bangmao Wang
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

Review 6.  Review of primary sclerosing cholangitis with increased IgG4 levels.

Authors:  Charis D Manganis; Roger W Chapman; Emma L Culver
Journal:  World J Gastroenterol       Date:  2020-06-21       Impact factor: 5.742

7.  Primary sclerosing cholangitis with increased immunoglobulin G4 levels: A case report.

Authors:  Qing-Ling Chen; Rui Zhong; Xiao-Xue Zhang; Li-Na Feng; Xiao-Yu Wen; Qing-Long Jin
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.